ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109154 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109154; 2) Community: the network communities that were significantly associated with the response to NSC 109154; 3) Molecule: the relationships between components within communities and NSC 109154; 4) MDR: the compounds that were significantly associated with the NSC 109154.

NSC Compound Enrichment Correlation
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.040397842611974 0.41770785
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.040397842611974 0.61114841
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.040397842611974 0.63909949
NSC 656243 Benzo[1,2-b:5,4-b']dithiophene-2-carboxylic acid, 4,8-dioxo- 0.040397842611974 0.14049422
NSC 666034 Carquniostatin B 0.040397842611974 0.64966853
NSC 666787 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate 0.040397842611974 0.2802852
NSC 668264 Null 0.040397842611974 0.53423561
NSC 681279 5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) 0.040397842611974 0.56551887
NSC 689540 Null 0.040397842611974 0.46911885
NSC 693702 Gambogic acid 0.040397842611974 0.59664609
Total:64  Current:54    [First] [Prev] [Next] [Last]